Pliant Therapeutics, Inc. (PLRX)

Pliant Therapeutics Statistics

Total Valuation

PLRX has a market cap or net worth of $94.63 million. The enterprise value is -$89.77 million.

Market Cap	94.63M
Enterprise Value	-89.77M

Important Dates

The last earnings date was Thursday, November 6, 2025, after market close.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

PLRX has 61.45 million shares outstanding. The number of shares has increased by 1.52% in one year.

Current Share Class	61.45M
Shares Outstanding	61.45M
Shares Change (YoY)	+1.52%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	2.52%
Owned by Institutions (%)	68.17%
Float	50.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.46
P/TBV Ratio	0.46
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.93, with a Debt / Equity ratio of 0.30.

Current Ratio	13.93
Quick Ratio	13.77
Debt / Equity	0.30
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-58.31

Financial Efficiency

Return on equity (ROE) is -64.27% and return on invested capital (ROIC) is -35.63%.

Return on Equity (ROE)	-64.27%
Return on Assets (ROA)	-32.87%
Return on Invested Capital (ROIC)	-35.63%
Return on Capital Employed (ROCE)	-73.33%
Revenue Per Employee	n/a
Profits Per Employee	-$1.03M
Employee Count	171
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -87.65% in the last 52 weeks. The beta is 1.30, so PLRX's price volatility has been higher than the market average.

Beta (5Y)	1.30
52-Week Price Change	-87.65%
50-Day Moving Average	1.59
200-Day Moving Average	1.70
Relative Strength Index (RSI)	46.65
Average Volume (20 Days)	722,496

Short Selling Information

The latest short interest is 3.72 million, so 6.06% of the outstanding shares have been sold short.

Short Interest	3.72M
Short Previous Month	3.83M
Short % of Shares Out	6.06%
Short % of Float	7.30%
Short Ratio (days to cover)	4.04

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-189.92M
Pretax Income	-175.50M
Net Income	-175.50M
EBITDA	-188.13M
EBIT	-189.92M
Earnings Per Share (EPS)	-$2.87

Balance Sheet

The company has $241.80 million in cash and $59.86 million in debt, giving a net cash position of $181.94 million or $2.96 per share.

Cash & Cash Equivalents	241.80M
Total Debt	59.86M
Net Cash	181.94M
Net Cash Per Share	$2.96
Equity (Book Value)	200.31M
Book Value Per Share	3.26
Working Capital	227.96M

Cash Flow

In the last 12 months, operating cash flow was -$158.21 million and capital expenditures -$583,000, giving a free cash flow of -$158.79 million.

Operating Cash Flow	-158.21M
Capital Expenditures	-583,000
Free Cash Flow	-158.79M
FCF Per Share	-$2.58

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PLRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.52%
Shareholder Yield	-1.52%
Earnings Yield	-190.40%
FCF Yield	-172.28%

Analyst Forecast

The average price target for PLRX is $3.79, which is 146.10% higher than the current price. The consensus rating is "Hold".

Price Target	$3.79
Price Target Difference	146.10%
Analyst Consensus	Hold
Analyst Count	11
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-9.61%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2